n-nitrosoarginine has been researched along with calcimycin in 1 studies
| Studies (n-nitrosoarginine) | Trials (n-nitrosoarginine) | Recent Studies (post-2010) (n-nitrosoarginine) | Studies (calcimycin) | Trials (calcimycin) | Recent Studies (post-2010) (calcimycin) |
|---|---|---|---|---|---|
| 13 | 0 | 2 | 11,946 | 40 | 444 |
| Protein | Taxonomy | n-nitrosoarginine (IC50) | calcimycin (IC50) |
|---|---|---|---|
| XBP1 | Homo sapiens (human) | 1.41 | |
| DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 0.16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferro, TJ; Johnson, A; Phelps, DT | 1 |
1 other study(ies) available for n-nitrosoarginine and calcimycin
| Article | Year |
|---|---|
Tumor necrosis factor-alpha decreases pulmonary artery endothelial nitrovasodilator via protein kinase C.
Topics: Animals; Arginine; Calcimycin; Cattle; Endothelium, Vascular; Nitrites; Nitro Compounds; Nitroso Compounds; omega-N-Methylarginine; Peroxides; Protein Kinase C; Pulmonary Artery; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; Vasodilator Agents | 1994 |